Clinical Trials in Jieyang, China
3 recruiting
Showing 1–10 of 10 trials
Recruiting
Not Applicable
Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis
Rheumatoid Arthritis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University130 enrolled5 locationsNCT06301373
Recruiting
Phase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
LeonaBio500 enrolled224 locationsNCT05696626
Recruiting
Phase 4
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
CKD (Chronic Kidney Disease) Stage 5D
Guangdong Provincial People's Hospital9,000 enrolled139 locationsNCT04381143
Recruiting
Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis
Head and Neck CancerRadiation-Induced Mucositis
Nanfang Hospital, Southern Medical University264 enrolled4 locationsNCT06307327
Recruiting
Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)
Tricuspid Regurgitation
Sun Yat-sen University3,000 enrolled7 locationsNCT06926959
Recruiting
Phase 3
Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
uremic pruritus
Qilu Pharmaceutical (Hainan) Co., Ltd.194 enrolled3 locationsNCT06446310
Recruiting
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
ImmunotherapyBiomarkerHyperprogression
Nanfang Hospital, Southern Medical University374 enrolled5 locationsNCT06276088
Recruiting
Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
Head and Neck CancerNasopharyngeal CarcinomaBiomarker+1 more
Nanfang Hospital, Southern Medical University300 enrolled5 locationsNCT06307314
Recruiting
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
Aortic Valve Disease
Sun Yat-sen University2,000 enrolled7 locationsNCT06069232
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SAF-189s in Non-small Cell Lung Cancer (NSCLC) Patients
Advanced Solid TumorAdvanced CancerLung Cancer, Nonsmall Cell
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.280 enrolled41 locationsNCT04237805